Skip to main content
. Author manuscript; available in PMC: 2015 Feb 1.
Published in final edited form as: Pharm Res. 2014 Feb;31(2):436–448. doi: 10.1007/s11095-013-1173-6

Figure 3.

Figure 3

Fractional activity of lysozyme released from implants prepared from AB10 di-block copolymer with (B) or without co-encapsulated 3% MgCO3 (A), and ABA10 tri-block copolymer with (D) or without co-encapsulated 3% MgCO3 (C). Lysozyme activity was not evaluated after 2 weeks from implants in (B) because release was complete by the two-week time point. Bars represent mean ± SEM, n=3.